Drug Treatment of Sleep Disorders (Hardcover, 2015 ed.)

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Milestones in Drug Therapy
Release date:	December 2014
First published:	2015
Editors:	Antonio Guglietta
Dimensions:	235 x 155 x 19mm (L x W x T)
Format:	Hardcover
Pages:	297
Edition:	2015 ed.
ISBN-13:	978-3-319-11513-9
Categories:	Books > Medicine > Other branches of medicine > Psychiatry Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Nursing & ancillary services > Specific disorders & therapies > Sleep disorders Promotions
LSN:	3-319-11513-8
Barcode:	9783319115139

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!